112 related articles for article (PubMed ID: 6249392)
1. Preparation and properties of glucagon analogs prepared by semi-synthesis from CNBr-glucagon.
Wright DE; Hruby VJ; Rodbell M
Biochim Biophys Acta; 1980 Aug; 631(1):49-58. PubMed ID: 6249392
[TBL] [Abstract][Full Text] [Related]
2. Structure-function relationships in glucagon: properties of highly purified des-His-1-, monoiodo-, and (des-Asn-28, Thr-29)(homoserine lactone-27)-glucagon.
Lin MC; Wright DE; Hruby VJ; Rodbell M
Biochemistry; 1975 Apr; 14(8):1559-63. PubMed ID: 164891
[TBL] [Abstract][Full Text] [Related]
3. Glucagon carboxyl-terminal derivatives: preparation, purification, and characterization.
England RD; Jones BN; Flanders KC; Coolican SA; Rothgeb TM; Gurd RS
Biochemistry; 1982 Mar; 21(5):940-50. PubMed ID: 7074063
[TBL] [Abstract][Full Text] [Related]
4. Structure-conformation-activity studies of glucagon and semi-synthetic glucagon analogs.
Hruby VJ
Mol Cell Biochem; 1982 Apr; 44(1):49-64. PubMed ID: 6283336
[TBL] [Abstract][Full Text] [Related]
5. Preparation of 2-thioltryptophan-glucagon and (tryptophan-S-glucagon)2. Differences in binding to the glucagon receptor in the hepatic adenylate cyclase system.
Wright DE; Rodbell M
J Biol Chem; 1980 Nov; 255(22):10884-7. PubMed ID: 7430160
[TBL] [Abstract][Full Text] [Related]
6. Semisynthetic glucagon derivatives for structure-function studies.
Hruby VJ; Wright DE; Lin MC; Rodbell M
Metabolism; 1976 Nov; 25(11 Suppl 1):1323-5. PubMed ID: 185491
[No Abstract] [Full Text] [Related]
7. Differential acid stabilities of citraconylated amino groups of glucagon. Preparation of N alpha-citraconyl glucagon and evaluation of its biological properties.
Liepnieks JJ; Epand RM
Biochim Biophys Acta; 1982 Oct; 707(2):171-7. PubMed ID: 6291617
[TBL] [Abstract][Full Text] [Related]
8. Synthetic peptide antagonists of glucagon.
Unson CG; Andreu D; Gurzenda EM; Merrifield RB
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
[TBL] [Abstract][Full Text] [Related]
9. Lipolytic and adenyl-cyclase-stimulating activity of glucagon 1-6: comparison with glucagon derivatives chemically modified in the 7-29 sequence.
Jean-Baptiste E; Rizack MA; Epand RM
Biosci Rep; 1982 Oct; 2(10):819-24. PubMed ID: 7171745
[TBL] [Abstract][Full Text] [Related]
10. Effect of specific trinitrophenylation of the lysine epsilon amino group of glucagon on receptor binding and adenylate cyclase activation.
Liepnieks JJ; Epand RM
Arch Biochem Biophys; 1983 Aug; 225(1):102-9. PubMed ID: 6311099
[TBL] [Abstract][Full Text] [Related]
11. The role of nonspecific hydrophobic interactions in the biological activity of N epsilon-acyl derivatives of glucagon. Studies of conformation, receptor binding, and adenylate cyclase activation.
Carrey EA; Epand RM
J Biol Chem; 1982 Sep; 257(18):10624-30. PubMed ID: 6286664
[TBL] [Abstract][Full Text] [Related]
12. N alpha-Malto-glucagon and N alpha-malto, S-methyl methionine27-glucagon: preparation and characterization of two partial agonists.
Coolican SA; Gurd RS
Arch Biochem Biophys; 1984 Aug; 232(2):450-7. PubMed ID: 6380408
[TBL] [Abstract][Full Text] [Related]
13. A reassessment of structure-function relationships in glucagon. Glucagon1-21 is a full agonist.
Wright DE; Hruby VJ; Rodbell M
J Biol Chem; 1978 Sep; 253(18):6338-40. PubMed ID: 210180
[TBL] [Abstract][Full Text] [Related]
14. Properties of amidinated glucagons.
Wright DE; Rodbell M
Eur J Biochem; 1980 Oct; 111(1):11-6. PubMed ID: 7439177
[TBL] [Abstract][Full Text] [Related]
15. Glucagon antagonists. Synthesis and inhibitory properties of Asp3-containing glucagon analogs.
Andreu D; Merrifield RB
Eur J Biochem; 1987 May; 164(3):585-90. PubMed ID: 3032623
[TBL] [Abstract][Full Text] [Related]
16. Semisynthetic D-His1,N epsilon-acetimidoglucagon: structure-function relationships.
Mahrenholz AM; Flanders KC; Hoosein NM; Gurd FR; Gurd RS
Arch Biochem Biophys; 1987 Sep; 257(2):379-86. PubMed ID: 2821912
[TBL] [Abstract][Full Text] [Related]
17. Glucagon antagonists: contribution to binding and activity of the amino-terminal sequence 1-5, position 12, and the putative alpha-helical segment 19-27.
Unson CG; Gurzenda EM; Iwasa K; Merrifield RB
J Biol Chem; 1989 Jan; 264(2):789-94. PubMed ID: 2536024
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent glucagon derivatives. I. Synthesis and characterisation of fluorescent glucagon derivatives.
Heithier H; Ward LD; Cantrill RC; Klein HW; Im MJ; Pollak G; Freeman B; Schiltz E; Peters R; Helmreich EJ
Biochim Biophys Acta; 1988 Oct; 971(3):298-306. PubMed ID: 2844291
[TBL] [Abstract][Full Text] [Related]
19. Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase.
Krstenansky JL; Trivedi D; Hruby VJ
Biochemistry; 1986 Jul; 25(13):3833-9. PubMed ID: 3017406
[TBL] [Abstract][Full Text] [Related]
20. Glucagon1-6 binds to the glucagon receptor and activates hepatic adenylate cyclase.
Wright DE; Rodbell M
J Biol Chem; 1979 Jan; 254(2):268-9. PubMed ID: 216670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
